Advertisement
Screener

Nuvectis Pharma, Inc. (NVCT) ROA

Nuvectis Pharma, Inc. (NVCT) ROA

  • 2026-06-30: ROA -124.45%.
  • 2026-03-31: ROA -106.94%.
  • 2025-12-31: ROA -83.39%.
  • 2025-09-30: ROA -71.31%.

Complete source-backed roa history.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-124.45%
2026-03-31-106.94%
2025-12-31-83.39%
2025-09-30-71.31%
2025-06-30-81.71%
2025-03-31-66.87%
2024-12-31-102.11%
2024-09-30-111.94%
2024-06-30-115.32%
2024-03-31-113.53%
2023-12-31-116.03%
2023-09-30-100.32%
2023-06-30-89.53%
2023-03-31-124.57%
2022-12-31-93.53%
2022-09-30-58.92%
2022-06-30-94.40%
2022-03-31-89.74%
2021-12-31-193.63%

Annual ROA

DateROA
2025-12-31-83.39%
2024-12-31-102.11%
2023-12-31-116.03%
2022-12-31-93.53%
2021-12-31-193.63%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Verastem, Inc. (VSTM)United States$0.706B-1.71
IRONWOOD PHARMACEUTICALS INC (IRWD)United States$0.694B5.37
Climb Bio, Inc. (CLYM)United States$0.683B-13.03
COLLEGIUM PHARMACEUTICAL, INC (COLL)United States$0.737B24.57
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61
Faeth Therapeutics, Inc. (FTH)United States$0.750B
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
Wave Life Sciences, Inc. (WVE)$0.780B-5.56